<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, implementation of a viral hepatitis response must aim to optimise the viral hepatitis care cascade by substantially improving testing rates, linkage to care and treatment numbers. The case of Egypt (and Iceland, see Appendix 
 <xref rid="liv14222-sup-0001" ref-type="supplementary-material">S1</xref>) demonstrates that concerted efforts enable substantial advances towards the WHO targets of 90% of people diagnosed and 80% of eligible people treated.
 <xref rid="liv14222-bib-0030" ref-type="ref">30</xref>, 
 <xref rid="liv14222-bib-0065" ref-type="ref">65</xref>, 
 <xref rid="liv14222-bib-0066" ref-type="ref">66</xref>
</p>
